FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149471995> ?p ?o ?g. }

• W2149471995 endingPage "1544" @default.
• W2149471995 startingPage "1537" @default.
• W2149471995 abstract "We analyzed the effect of hypertension on postischemic vasculogenesis. Ischemia was induced by right femoral artery ligature in Wistar Kyoto rats (WKY) or spontaneously hypertensive rats (SHR) treated with or without angiotensin-converting enzyme inhibitor (Perindopril, 0.76 mg/kg/d) and angiotensin type 1 receptor blocker (losartan, 30 mg/kg/d). Basal postischemic neovascularization was reduced in SHR compared to WKY ( P <0.05, n=8). Treatment with ACE inhibitor or angiotensin type 1 receptor blocker decreased blood pressure levels by 1.4- and 1.3-fold ( P <0.001), respectively and restored vessel growth in SHR to WKY levels. Interestingly, 14 days after bone-marrow mononuclear cell (BM-MNC) transfusion, angiographic scores, capillary density, and foot perfusion were decreased by 1.4-, 1.5-, and 1.2-fold, respectively in SHR transfused with BM-MNCs isolated from SHR compared to those receiving BM-MNCs of WKY ( P <0.05, n=6). Alteration in BM-MNCs proangiogenic potential was likely related to the reduction in their ability to mobilize into peripheral circulation, as revealed by the 2.9-fold decrease in number of circulating CD34+/CD117+ cells ( P <0.001) and to differentiate into cells with endothelial phenotype, as revealed by the 2.1-fold reduction in percentages of DilLDL/BS-1 lectin positive cells ( P <0.001). In addition, reactive oxygen species (ROS) levels were increased by 2.2-fold in SHR BM-MNCs compared to WKY BM-MNCs ( P <0.01), as assessed by L-012 luminescence. Cotreatment with ACE inhibitor, angiotensin type 1 receptor blocker, or antioxidants (NAC 3 mmol/L, Apocynin 200 μmol/L) reduced ROS levels, improved the number of DilLDL/BS-1 lectin-positive cells by around 1.5-fold, and restored BM-MNCs proangiogenic effects in ischemic hindlimb. In conclusion, alteration in progenitor cell proangiogenic function may participate to the hypertension-induced impairment in postischemic revascularization." @default.
• W2149471995 created "2016-06-24" @default.
• W2149471995 creator A5008214462 @default.
• W2149471995 creator A5023443145 @default.
• W2149471995 creator A5025720268 @default.
• W2149471995 creator A5026377797 @default.
• W2149471995 creator A5036965490 @default.
• W2149471995 creator A5039546853 @default.
• W2149471995 creator A5054638945 @default.
• W2149471995 creator A5089583231 @default.
• W2149471995 date "2008-06-01" @default.
• W2149471995 modified "2023-10-02" @default.
• W2149471995 title "Hypertension Impairs Postnatal Vasculogenesis" @default.
• W2149471995 cites W1497461844 @default.
• W2149471995 cites W1969855616 @default.
• W2149471995 cites W1976291192 @default.
• W2149471995 cites W1987895314 @default.
• W2149471995 cites W1988126593 @default.
• W2149471995 cites W1997234857 @default.
• W2149471995 cites W1998100693 @default.
• W2149471995 cites W1999582512 @default.
• W2149471995 cites W1999880393 @default.
• W2149471995 cites W2009046724 @default.
• W2149471995 cites W2035540389 @default.
• W2149471995 cites W2038827789 @default.
• W2149471995 cites W2039284766 @default.
• W2149471995 cites W2042761977 @default.
• W2149471995 cites W2043909669 @default.
• W2149471995 cites W2054095354 @default.
• W2149471995 cites W2061945278 @default.
• W2149471995 cites W2072342077 @default.
• W2149471995 cites W2080836044 @default.
• W2149471995 cites W2085652180 @default.
• W2149471995 cites W2098767125 @default.
• W2149471995 cites W2099273954 @default.
• W2149471995 cites W2103571483 @default.
• W2149471995 cites W2104653409 @default.
• W2149471995 cites W2108246384 @default.
• W2149471995 cites W2112267108 @default.
• W2149471995 cites W2113220448 @default.
• W2149471995 cites W2115965460 @default.
• W2149471995 cites W2127872440 @default.
• W2149471995 cites W2132418620 @default.
• W2149471995 cites W2142041241 @default.
• W2149471995 cites W2142108077 @default.
• W2149471995 cites W2156098063 @default.
• W2149471995 cites W2157677292 @default.
• W2149471995 cites W2160741229 @default.
• W2149471995 cites W2320657577 @default.
• W2149471995 cites W2341645956 @default.
• W2149471995 cites W4292820724 @default.
• W2149471995 doi "https://doi.org/10.1161/hypertensionaha.107.109066" @default.
• W2149471995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18426993" @default.
• W2149471995 hasPublicationYear "2008" @default.
• W2149471995 type Work @default.
• W2149471995 sameAs 2149471995 @default.
• W2149471995 citedByCount "51" @default.
• W2149471995 countsByYear W21494719952012 @default.
• W2149471995 countsByYear W21494719952013 @default.
• W2149471995 countsByYear W21494719952014 @default.
• W2149471995 countsByYear W21494719952015 @default.
• W2149471995 countsByYear W21494719952016 @default.
• W2149471995 countsByYear W21494719952017 @default.
• W2149471995 countsByYear W21494719952018 @default.
• W2149471995 countsByYear W21494719952019 @default.
• W2149471995 countsByYear W21494719952020 @default.
• W2149471995 crossrefType "journal-article" @default.
• W2149471995 hasAuthorship W2149471995A5008214462 @default.
• W2149471995 hasAuthorship W2149471995A5023443145 @default.
• W2149471995 hasAuthorship W2149471995A5025720268 @default.
• W2149471995 hasAuthorship W2149471995A5026377797 @default.
• W2149471995 hasAuthorship W2149471995A5036965490 @default.
• W2149471995 hasAuthorship W2149471995A5039546853 @default.
• W2149471995 hasAuthorship W2149471995A5054638945 @default.
• W2149471995 hasAuthorship W2149471995A5089583231 @default.
• W2149471995 hasConcept C126322002 @default.
• W2149471995 hasConcept C134018914 @default.
• W2149471995 hasConcept C170493617 @default.
• W2149471995 hasConcept C201750760 @default.
• W2149471995 hasConcept C2780288358 @default.
• W2149471995 hasConcept C28328180 @default.
• W2149471995 hasConcept C2908929049 @default.
• W2149471995 hasConcept C54355233 @default.
• W2149471995 hasConcept C60781801 @default.
• W2149471995 hasConcept C71924100 @default.
• W2149471995 hasConcept C86803240 @default.
• W2149471995 hasConceptScore W2149471995C126322002 @default.
• W2149471995 hasConceptScore W2149471995C134018914 @default.
• W2149471995 hasConceptScore W2149471995C170493617 @default.
• W2149471995 hasConceptScore W2149471995C201750760 @default.
• W2149471995 hasConceptScore W2149471995C2780288358 @default.
• W2149471995 hasConceptScore W2149471995C28328180 @default.
• W2149471995 hasConceptScore W2149471995C2908929049 @default.
• W2149471995 hasConceptScore W2149471995C54355233 @default.
• W2149471995 hasConceptScore W2149471995C60781801 @default.
• W2149471995 hasConceptScore W2149471995C71924100 @default.
• W2149471995 hasConceptScore W2149471995C86803240 @default.
• W2149471995 hasIssue "6" @default.

• next